Corticosteroids in critically ill patients: A long and winding road [1]

Archives of Surgery

Volumn 141, Issue 9, 2006, Pages 945-

  Salluh, Jorge Ibrain Figueira ^a   Fuks, Anna Gabriela ^b  

^a Hospital Barra D'Or   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; CRITICALLY ILL PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LETTER; LOW DRUG DOSE; MORTALITY; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 33748807068     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.9.945-a     Document Type: Letter

References (6)

1. Britt RC, Devine A, Swallen KC, et al. Corticosteroid use in the intensive care unit: at what cost? Arch Surg. 2006;141:145-149.
2. Beishuizen A, Thijs LG. The immunoneuroendocrine axis in critical illness: beneficial adaptation or neuroendocrine exhaustion? Curr Opin Crit Care. 2004;10:461-467.
3. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329:480.
4. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
5. Salluh JI, Verdeal JC, Mello GW, et al. Cortisol levels in patients with severe community-acquired pneumonia. Intensive Care Med. 2006;32:595-598.
6. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171:242-248.